German American Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-392
Closed -$204K 125
2024
Q3
$204K Sell
392
-10
-2% -$5.34K 0.02% 126
2024
Q2
$218K Buy
+402
New +$212K 0.03% 120

Other funds holding ELV

German American Bancorp's ELV Position: Q4 2024 in Review

German American Bancorp sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 392 shares — an estimated $204K sold.

German American Bancorp first reported a position in ELV in Q2 2024 and held it in 2 quarters. The position peaked at $218K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • German American Bancorp reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • German American Bancorp sold 392 Elevance Health shares in Q4 2024, an estimated $204K.
  • German American Bancorp first reported a position in Elevance Health in Q2 2024 and held it in 2 quarters.
  • German American Bancorp's Elevance Health position peaked at $218K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on German American Bancorp's 13F filing for Q4 2024, filed 13 Feb 2025.